logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumab/Nivolumab/Nivolumab/relatlimabVarious toxicities: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2025年 / 2056卷 / 1期
关键词:
D O I:
10.1007/s40278-025-81637-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:265 / 265
相关论文
共 50 条
  • [21] Ipilimumab/nivolumab/pembrolizumabVarious toxicities
    Reactions Weekly, 2023, 1958 (1) : 289 - 289
  • [22] Ipilimumab/Nivolumab/PembrolizumabMultiple toxicities
    Reactions Weekly, 2024, 1991 (1) : 124 - 124
  • [23] Ipilimumab/nivolumab/pembrolizumabHepatitis: case report
    Reactions Weekly, 2020, 1834 (1) : 141 - 141
  • [24] Ipilimumab/nivolumab/pembrolizumabMyocarditis: case report
    Reactions Weekly, 2022, 1914 (1) : 266 - 266
  • [25] Ipilimumab/nivolumab/pembrolizumabHypopituitarism: case report
    Reactions Weekly, 2021, 1882 (1) : 256 - 256
  • [26] Ipilimumab/nivolumab/pembrolizumabPneumonitis: case report
    Reactions Weekly, 2018, 1713 (1) : 204 - 204
  • [27] Ipilimumab/nivolumab/vancomycinVarious toxicities and off label use: case report
    Reactions Weekly, 2023, 1947 (1) : 241 - 241
  • [28] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 29 case reports
    Reactions Weekly, 2021, 1859 (1) : 201 - 201
  • [29] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
    Reactions Weekly, 2019, 1751 (1) : 221 - 221
  • [30] Ipilimumab/nivolumab/pembrolizumabVarious toxicities : 5 case reports
    Reactions Weekly, 2024, 2019 (1) : 231 - 231
← 12345 →